Safety against cervical precancer and cancer following negative human papillomavirus and Papanicolaou test results in human immunodeficiency virus-infected women.
American Society for Clinical Pathology Institute, Washington, DC 20005, USA. philip.castle@ascp.org
Philip E
PE
Castle
Barbara
B
Fetterman
Nancy
N
Poitras
Thomas
T
Lorey
Walter
W
Kinney
D000328:Adult; D000368:Aged; D052685:Alphapapillomavirus / Q000302:isolation & purification; D002140:California / Q000453:epidemiology; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D055088:Early Detection of Cancer; D005260:Female; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D065006:Papanicolaou Test; D011159:Population Surveillance / Q000379:methods; D011230:Precancerous Conditions / Q000175:diagnosis* / Q000453:epidemiology / Q000821:virology*; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology*; D014626:Vaginal Smears; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology